The following is a listing of myeloma treatments associated with this tag.
View all treatments in development for myeloma patients around the US.
The following is a listing of treatments in development for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
The following is a listing of treatments in development for patients with multiple myeloma who have received one to two prior lines of therapy.
The following is a listing of treatments in development for patients with multiple myeloma who have received three or more prior lines of therapy.
The following is a listing of myeloma clinical trials associated with this tag.
View all active clinical trials around the US.
A Study to See if Anti-BCMA CAR T-Cell Therapy Can Be Made from People with Multiple Myeloma Who Have Had a Stem Cell Transplant
IDE-CEL POST HEMATOPOIETIC CELL TRANSPLANT
SparkCures Verified Accurate, up-to-date information. Learn more
A Feasibility Study Following a Phase 2a Design to Demonstrate Successful Local Manufacture of Chimeric Ant...
LOCAL MANUFACTURE OF CAR-T CELL PRODUCTSA Phase 1/1b Safety Study of PRGN-3006 Adoptive Cellular Therapy in Patients With CD33-Positive Relapsed or...
PRGN-3006 ADOPTIVE CELLULAR THERAPYA Phase I Study of CD19-Targeted 19(T2)28z1xx Chimeric Antigen Receptor (CAR) Modified T Cells in Adult Pat...
CD19-TARGETED 19(T2)28Z1XX CAR-TA Phase Ib Clinical Study of Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (CT103A...
BCMA CAR-T CELL INJECTION (CT103A)Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antige...
AUTOLOGOUS STEM CELL TRANSPLANT POST CAR-TPhase I Study of BCMA-TGF-BETA Insensitive Armored CAR T Cells in Patients With Relapsed and/or Refractory ...
BCMA-TGF-BETA INSENSITIVE ARMORED CAR T CELLSThe following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
SparkCures Verified Accurate, up-to-date information. Learn more
The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
SparkCures Verified Accurate, up-to-date information. Learn more
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antige...
AUTOLOGOUS STEM CELL TRANSPLANT POST CAR-TThe following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
A Study to See if Anti-BCMA CAR T-Cell Therapy Can Be Made from People with Multiple Myeloma Who Have Had a Stem Cell Transplant
IDE-CEL POST HEMATOPOIETIC CELL TRANSPLANTSparkCures Verified Accurate, up-to-date information. Learn more
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antige...
AUTOLOGOUS STEM CELL TRANSPLANT POST CAR-TThe following is a listing of clinical trials for patients with Smoldering Myeloma.
The following is a listing of myeloma centers associated with this tag.
The following is a listing of myeloma tags that are associated with this tag.
B-Cell Maturation Antigen (BCMA)
B-Cell Maturation Antigen (BCMA) is a protein that may be found on the surface of myeloma cells. BCMA may be used as a target to help treatments find and destroy myeloma cells.
CD38
CD38 is a protein that may be found on the surface of many immune system cells (including multiple myeloma cells). This protein may be used as a way for treatments to target (or find) myeloma cells.